Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-056248

Options or other derivatives

  • Chief Legal Officer acquired 135,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DiFabio Andrea · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-11-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +135,000 135,000 D
Loading xslF345X03/doc4.xml…